RL

Ralf Lutterbüse

AM Amgen: 22 patents #87 of 2,867Top 4%
MA Micromet Ag: 6 patents #3 of 65Top 5%
Overall (All Time): #168,061 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12304952 Antibody constructs for DLL3 and CD3 Tobias Raum, Claudia Blümel, Christoph Dahlhoff, Patrick Hoffmann, Peter Kufer +2 more 2025-05-20
12297292 Antibody constructs for CDH19 and CD3 Shouhua Xiao, Zheng Pan, Dineli Wickramasinghe, Peter Kufer, Patrick Hoffmann +3 more 2025-05-13
12281172 Cross-species-specific PSMAxCD3 bispecific single chain antibody Peter Kufer, Tobias Raum, Roman Kischel, Patrick Hoffmann, Doris Rau +6 more 2025-04-22
11987633 Cross-species-specific single domain bispecific single chain antibody Peter Kufer, Tobias Raum, Roman Kischel, Patrick Hoffmann, Matthias Klinger +2 more 2024-05-21
11926666 Bispecific antibody constructs for CDH3 and CD3 Bertram Weiss, Anna-Lena Frisk, Ruprecht Zierz, Peter Kufer, Tobias Raum +6 more 2024-03-12
11661462 Optimized cross-species specific bispecific single chain antibody contructs Benno Rattel, Matthias Friedrich, Peter Kufer, Patrick Hoffmann, Tobias Raum +3 more 2023-05-30
11591396 Antibody constructs for DLL3 and CD3 Tobias Raum, Claudia Blümel, Christoph Dahlhoff, Patrick Hoffmann, Peter Kufer +2 more 2023-02-28
11498964 Antibody constructs for CDH19 and CD3 Shouhua Xiao, Zheng Pan, Dineli Wickramasinghe, M. Shawn Jeffries, Chadwick Terence King +8 more 2022-11-15
11472886 Cross-species-specific PSMAxCD3 bispecific single chain antibody Peter Kufer, Tobias Raum, Roman Kischel, Patrick Hoffmann, Doris Rau +6 more 2022-10-18
11028171 Bispecific antibody constructs for CDH3 and CD3 Bertram Weiss, Ann-Lena Frisk, Ruprecht Zierz, Peter Kufer, Tobias Raum +6 more 2021-06-08
10981998 Cross-species-specific single domain bispecific single chain antibody Peter Kufer, Tobias Raum, Roman Kischel, Patrick Hoffman, Matthias Klinger +2 more 2021-04-20
10851170 Antibody constructs for CD70 and CD3 Tobias Raum, Claudia Blümel, Wibke Deisting, Patrick Hoffmann, Elisabeth Nahrwold +2 more 2020-12-01
10683351 Antibody constructs for DLL3 and CD3 Tobias Raum, Claudia Blümel, Christoph Dahlhoff, Patrick Hoffmann, Peter Kufer +2 more 2020-06-16
10294300 Antibody constructs for DLL3 and CD3 Tobias Raum, Claudia Blümel, Christoph Dahlhoff, Patrick Hoffmann, Peter Kufer +2 more 2019-05-21
10059766 Antibody constructs for CDH19 and CD3 Shouhua Xiao, Zheng Pan, Dineli Wickramasinghe, M. Shawn Jeffries, Chadwick Terence King +8 more 2018-08-28
9982063 Pharmaceutical compositions with resistance to soluble CEA Petra Fluhr, Evelyne Schaller, Doris Rau, Susanne Mangold, Peter Kufer +3 more 2018-05-29
9765157 Antibody constructs for CDH19 and CD3 Shouhua Xiao, Zheng Pan, Dineli Wickramasinghe, Peter Kufer, Patrick Hoffmann +3 more 2017-09-19
9695250 Pharmaceutical compositions with resistance to soluble CEA Petra Fluhr, Evelyne Schaller, Doris Rau, Susanne Mangold, Peter Kufer +3 more 2017-07-04
8394926 Pharmaceutical compositions with resistance to soluble CEA Petra Mayer, Evelyne Schaller, Doris Rau, Susanne Mangold, Peter Kufer +3 more 2013-03-12
8101722 Less immunogenic binding molecules Peter Kufer, Ulla Lenkkeri-Schütz, Birgit Kohleisen 2012-01-24
7635472 Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders Peter Kufer, Birgit Kohleisen, Steven Zeman, Patrick Bauerle 2009-12-22
7575923 CD19xCD3 specific polypeptides and uses thereof Bernd Dorken, Gert Riethmuller, Peter Kufer, Ralf Bargou, Anja Löffler 2009-08-18
7435549 Method of identifying binding site domains that retain the capacity of binding to an epitope Peter Kufer, Tobias Raum, Katrin Borschert, Florian Zettl 2008-10-14
7112324 CD 19×CD3 specific polypeptides and uses thereof Bernd Dorken, Gert Riethmuller, Peter Kufer, Ralf Bargou, Anja Löffler 2006-09-26